Among paroxetine-based products on the international market, Seroxat is one of the more broadly distributed brands, registered in 40 countries. Its active ingredient is paroxetine, classified within the psychoanaleptics group and used as an antidepressant. The brand is a familiar one for travellers and expatriates who first encountered it in Europe or East Asia and now find themselves looking for the same medication in another regulatory environment.
Paroxetine is prescribed across a relatively wide span of psychiatric indications, including depression, generalized anxiety disorder, obsessive compulsive disorder, panic disorder with or without agoraphobia, and related anxiety presentations. The structured indication block further down this page lists each registered use exactly as it appears in the source data; the categories above are summarised at the level of the therapeutic area rather than at the level of any specific clinical decision.
Because Seroxat circulates across so many markets — examples include Germany, China, Egypt, Finland, and Croatia — travellers will frequently come across it, sometimes under the Seroxat brand and sometimes as a paroxetine-containing generic produced by a local manufacturer. National regulators differ in packaging, pack size, and prescribing pathway, and a pharmacist in the destination country is generally the most efficient route to confirming whether a paroxetine product on the shelf corresponds to what was prescribed at home.
Other antidepressants in the broader psychoanaleptics category are also widely available internationally under various molecules and brand names, but they are not interchangeable with paroxetine without medical input. Continuity of antidepressant therapy across borders — including any change of brand, switch to a generic, or interruption while travelling — is a clinical matter, and decisions about it belong with a treating healthcare provider rather than a pharmacy counter.
10/20/30 mg tablet
3 years.
Oral suspension
2 years (1 month after opening).
Not applicable.
10 mg tablet
Tablet core:
Dibasic calcium phosphate dihydrate (E341)
Sodium starch glycolate (Type A)
Magnesium stearate (E470b).
Tablet coating:
Hypromellose (E464)
Macrogol 400
Polysorbate 80 (E433)
Titanium dioxide (E171)
Iron oxide red (E172).
20 mg tablet
Tablet core:
Dibasic calcium phosphate dihydrate (E341)
Sodium starch glycolate (Type A)
Magnesium stearate (E470b).
Tablet coating:
Hypromellose (E464)
Macrogol 400
Polysorbate 80 (E433)
Titanium dioxide (E171).
30 mg tablet
Tablet core:
Dibasic calcium phosphate dihydrate (E341)
Sodium starch glycolate (Type A)
Magnesium stearate (E470b).
Tablet coating:
Hypromellose (E464)
Macrogol 400
Polysorbate 80 (E433)
Titanium dioxide (E171)
Indigo carmine (E132).
Oral suspension
Polacrilin potassium
Dispersible cellulose (E460)
Propylene glycol
Glycerol (E422)
Sorbitol (E420)
Methyl parahydroxybenzoate (E218)
Propyl parahydroxybenzoate (E216)
Sodium citrate dihydrate (E331)
Citric acid anhydrate (E330)
Sodium saccharin (E954)
Natural orange flavour
Natural lemon flavour
Colouring agent sunset yellow FCF (E110)
Simethicone emulsion
Purified water.
23 October 2015
SmithKline Beecham Limited
Great West Road
Brentford
Middlesex TW8 9GS.
trading as:
SmithKline Beecham Pharmaceuticals
Welwyn Garden City
Hertfordshire AL7 1EY
And/or
GlaxoSmithKline UK,
Stockley Park West,
Uxbridge,
Middlesex UB11 1BT
10/20/30 mg tablet
Do not store above 30°C.
Store in the original package in order to protect from light.
Oral suspension
Do not store above 25°C.
10 mg tablet
Child-resistant blister packs comprising opaque polyvinyl chloride (PVC) backed with aluminium foil laminated with paper.
Pack sizes: 14 and 28 tablets.
Not all pack sizes may be marketed.
20 mg tablet
Child-resistant blister packs comprising opaque polyvinyl chloride (PVC) backed with aluminium foil laminated with paper. Plastic containers (bottles) made of polypropylene, with polyethylene closures, may also be used.
Pack sizes: 50 x 1 tablet or 4, 10, 14, 20, 28, 30, 50, 56, 60, 98, 100, 250 and 500 tablets.
Not all pack sizes may be marketed.
30 mg tablet
Child-resistant blister packs comprising opaque polyvinyl chloride (PVC) backed with aluminium foil laminated with paper. Plastic containers (bottles) made of polypropylene, with polyethylene closures, may also be used.
Pack sizes: 28, 30, 56 and 60 tablets.
Not all pack sizes may be marketed.
Oral suspension
Amber glass bottle sealed with polypropylene child-resistant cap lined with a polyethylene wad.
A polypropylene measuring cup is included.
Pack size: 150 ml.
Seroxat Tablets 10 mg: 10592/0218
Seroxat Tablets 20 mg: 10592/0001
Seroxat Tablets 30 mg: 10592/0002
Seroxat Oral suspension:10592/0092
No special requirements.
Seroxat Tablets 10 mg:
Date of first authorisation: 29/07/2005
Date of latest renewal: 27/09/2010
Seroxat Tablets 20 mg and 30 mg:
Date of first authorisation: 11/12/1990
Date of latest renewal: 27/09/2010
Seroxat Oral suspension
Date of first authorisation: 08/01/1997
Date of latest renewal: 27/09/2010
Seroxat is prescribed across a range of psychiatric indications, including depression, generalized anxiety disorder, obsessive compulsive disorder, panic disorder, panic attacks, and agoraphobia. Its active ingredient sits within the psychoanaleptics category and is used as an antidepressant. The structured indication list further down this page reflects each registered use as recorded in the regulatory data for the markets where Seroxat is sold.
Seroxat contains paroxetine, a psychoanaleptic medication used as an antidepressant. Paroxetine is the same molecule whether dispensed under the Seroxat brand or as a paroxetine-containing generic, and internationally the same active ingredient circulates under multiple commercial names depending on the manufacturer and the regulatory market in which the product is registered.
Seroxat is registered in 40 countries, spanning Western and Eastern Europe, parts of the Middle East and North Africa, the Caucasus, and parts of East Asia. Examples include Germany, China, Egypt, Finland, Bulgaria, Hong Kong, and Croatia. If your country is not listed in the structured data on this page, a local pharmacist can usually confirm whether paroxetine is available locally under another brand name.
Paroxetine is sold under several brand names and as generic preparations in many of the markets where Seroxat is registered. Other antidepressants within the broader psychoanaleptics class also exist internationally, although they are not freely interchangeable — different molecules within the class have meaningfully different profiles. To identify a local paroxetine-containing product, search the active ingredient on Pill2Trip or ask a pharmacist.
Yes. Seroxat is a prescription medication, and antidepressant therapy is calibrated to an individual's history, concurrent medications, and clinical picture. This is particularly relevant for travellers and people relocating between countries, since prescription requirements, available brands, and generic equivalents differ across regulatory regimes. Any decision to start, stop, switch, or substitute paroxetine — including continuity of an existing prescription abroad — should involve a healthcare provider.
